Positively Sharing

After viral rebound, dolutegravir-based treatment more likely to suppress HIV

Reading Time: < 1 minute

Dolutegravir-based treatment is significantly more likely to result in re-suppression of HIV after viral rebound than treatment containing efavirenz, Read More

Exit mobile version